Format

Send to

Choose Destination
Expert Rev Neurother. 2005 Sep;5(5):683-90.

Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.

Author information

1
Huntsman Cancer Institute at the University of Utah, 2000 Circle of Hope, Ste 2152, Salt Lake City, UT 84112, USA. deborah.blumenthal@hsc.utah.edu

Abstract

Glioblastoma is an uncommon cancer, but one that is disproportionately represented in mortality rates. Recent developments in adjuvant chemotherapy have regenerated enthusiasm for the treatment of this tumor. Ongoing translational and clinical research has led to a greater understanding of the biologic and molecular behavior and heterogeneity of this tumor. Recent shifts in treatment standards, as well as further selective individualizing of therapies based on molecular information, promise progress for this difficult-to-treat neoplasm.

PMID:
16162092
DOI:
10.1586/14737175.5.5.683
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center